Inbrija and Limb injury - a phase IV clinical study of FDA data

Summary:

Limb injury is found among people who take Inbrija, especially for people who are male, 50-59 old.

The phase IV clinical study analyzes which people take Inbrija and have Limb injury. It is created by eHealthMe based on reports of 7,604 people who have side effects when taking Inbrija from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 18, 2023

7,604 people reported to have side effects when taking Inbrija.
Among them, 8 people (0.11%) have Limb injury.

What is Inbrija?

Inbrija has active ingredients of levodopa. eHealthMe is studying from 7,605 Inbrija users for its effectiveness, alternative drugs and more.

What is Limb injury?

Limb injury is found to be associated with 2,007 drugs and 1,043 conditions by eHealthMe.

Number of Inbrija and Limb injury reports submitted per year:

Gender of people who have Limb injury when taking Inbrija *:

female: 12.5 %
male: 87.5 %

Age of people who have Limb injury when taking Inbrija *:

Common drugs people take besides Inbrija *:

Carbidopa And Levodopa: 2 people, 25.00%
Vitamin D3: 1 person, 12.50%
Myrbetriq: 1 person, 12.50%
Fish Oil: 1 person, 12.50%
Duopa: 1 person, 12.50%

Common side effects people have besides Limb injury *:

Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle): 4 people, 50.00%
Device Occlusion: 3 people, 37.50%
Throat Irritation: 2 people, 25.00%
Muscle Strain (an injury to a muscle in which the muscle fibres tear): 1 person, 12.50%
Fall: 1 person, 12.50%
Cough: 1 person, 12.50%
Back Injury: 1 person, 12.50%

Common conditions people have *:

Parkinson's Disease: 8 people, 100.00%
On And Off Phenomenon: 3 people, 37.50%

* Approximation only. Some reports may have incomplete information.

Do you take Inbrija and have Limb injury?

Check whether Limb injury is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Limb injury and when was it recovered:

Limb injury in Inbrija

Expand to all the drugs that have ingredients of levodopa:

Limb injury and drugs with ingredients of levodopa

Alternative drugs to, pros and cons of Inbrija:

Inbrija (7,605 reports)

Common Inbrija side effects:

Browse all side effects of Inbrija:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Limb injury treatments and more:

Limb injury (27,453 reports)

COVID vaccines that are related to Limb injury:

Common drugs associated with Limb injury:

All the drugs that are associated with Limb injury:

Limb injury (2,007 drugs)

Common conditions associated with Limb injury:

All the conditions that are associated with Limb injury:

Limb injury (1,043 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levodopa (the active ingredients of Inbrija) and Inbrija (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.